Sunshine Biopharma Inc. (NASDAQ: SBFM ) on Wednesday announced it advanced its lead Coronavirus drug candidate into ...

These days, notices reading “Flu vaccination now available!” are posted in schools and hospitals everywhere. Some people are ...

Partnership Advances Gilead’s Global Access Strategy, Helping Turn Scientific Innovation into Public Health Impact – FOSTER CITY, Calif. -- (BUSINESS WIRE)--Sep. 15, 2026-- Gilead Sciences, Inc.

SHELTON, CT / ACCESS Newswire / September 15, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...

Researchers, executives and engineers who left OpenAI, Google and Anthropic have spent years warning about safety failures, ...

Warm coastal weather makes outdoor living fantastic, but humid subtropical climates are also ideal breeding grounds for ...

SHELTON, CT / ACCESS Newswire / September 15, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces ...

Social media chatter centers on Sunshine Biopharma's progress with its lead coronavirus drug candidate, now entering ...

Can Oncolytic Viruses Make CAR-T-Cell Therapy More Adaptable in B-Cell Malignancies? / B-cell malignancies, cancer, CAR-T ...

The granite box inside the King’s Chamber at Giza is too wide to have passed through the finished corridors. It had to be put ...

Spread the loveImagine a world where the very tools we created to help us suddenly turn against us, not with a bang and a Hollywood-style robot uprising, but with subtle, insidious acts of deception ...

William A. Haseltine is a former professor at Harvard Medical School and the School of Public Health. He is the founder of multiple biotechnology companies and the chair of the nonprofit ACCESS Health ...